Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2019 Aug 09;29432:12132-12145. doi: 10.1074/jbc.RA118.006253.
Show Gene links
Show Anatomy links
Discovery of an intrasubunit nicotinic acetylcholine receptor-binding site for the positive allosteric modulator Br-PBTC.
Norleans J
,
Wang J
,
Kuryatov A
,
Leffler A
,
Doebelin C
,
Kamenecka TM
,
Lindstrom J
.
???displayArticle.abstract???
Nicotinic acetylcholine receptor (nAChR) ligands that lack agonist activity but enhance activation in the presence of an agonist are called positive allosteric modulators (PAMs). nAChR PAMs have therapeutic potential for the treatment of nicotine addiction and several neuropsychiatric disorders. PAMs need to be selectively targeted toward certain nAChR subtypes to tap this potential. We previously discovered a novel PAM, (R)-7-bromo-N-(piperidin-3-yl)benzo[b]thiophene-2-carboxamide (Br-PBTC), which selectively potentiates the opening of α4β2*, α2β2*, α2β4*, and (α4β4)2α4 nAChRs and reactivates some of these subtypes when desensitized (* indicates the presence of other subunits). We located the Br-PBTC-binding site through mutagenesis and docking in α4. The amino acids Glu-282 and Phe-286 near the extracellular domain on the third transmembrane helix were found to be crucial for Br-PBTC's PAM effect. E282Q abolishes Br-PBTC potentiation. Using (α4E282Qβ2)2α5 nAChRs, we discovered that the trifluoromethylated derivatives of Br-PBTC can potentiate channel opening of α5-containing nAChRs. Mutating Tyr-430 in the α5 M4 domain changed α5-selectivity among Br-PBTC derivatives. There are two kinds of α4 subunits in α4β2 nAChRs. Primary α4 forms an agonist-binding site with another β2 subunit. Accessory α4 forms an agonist-binding site with another α4 subunit. The pharmacological effect of Br-PBTC depends both on its own and agonists' occupancy of primary and accessory α4 subunits. Br-PBTC reactivates desensitized (α4β2)2α4 nAChRs. Its full efficacy requires intact Br-PBTC sites in at least one accessory and one primary α4 subunit. PAM potency increases with higher occupancy of the agonist sites. Br-PBTC and its derivatives should prove useful as α subunit-selective nAChR PAMs.
Alcaino,
Role of the Cys Loop and Transmembrane Domain in the Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors.
2017, Pubmed,
Xenbase
Alcaino,
Role of the Cys Loop and Transmembrane Domain in the Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors.
2017,
Pubmed
,
Xenbase
Arnold,
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.
2006,
Pubmed
Arnold,
Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.
2012,
Pubmed
Bertrand,
Allosteric modulation of nicotinic acetylcholine receptors.
2007,
Pubmed
Biasini,
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information.
2014,
Pubmed
Bissantz,
A medicinal chemist's guide to molecular interactions.
2010,
Pubmed
Bordoli,
Protein structure homology modeling using SWISS-MODEL workspace.
2009,
Pubmed
Carignano,
Analysis of neuronal nicotinic acetylcholine receptor α4β2 activation at the single-channel level.
2016,
Pubmed
Deba,
LY2087101 and dFBr share transmembrane binding sites in the (α4)3(β2)2 Nicotinic Acetylcholine Receptor.
2018,
Pubmed
,
Xenbase
Domville,
An allosteric link connecting the lipid-protein interface to the gating of the nicotinic acetylcholine receptor.
2018,
Pubmed
Du,
Glycine receptor mechanism elucidated by electron cryo-microscopy.
2015,
Pubmed
Fowler,
Habenular α5 nicotinic receptor subunit signalling controls nicotine intake.
2011,
Pubmed
Frahm,
Aversion to nicotine is regulated by the balanced activity of β4 and α5 nicotinic receptor subunits in the medial habenula.
2011,
Pubmed
,
Xenbase
Gielen,
The desensitization gate of inhibitory Cys-loop receptors.
2015,
Pubmed
,
Xenbase
Glaab,
Building a virtual ligand screening pipeline using free software: a survey.
2016,
Pubmed
Grosdidier,
SwissDock, a protein-small molecule docking web service based on EADock DSS.
2011,
Pubmed
Grønlien,
Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
2007,
Pubmed
,
Xenbase
Harpsøe,
Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptors.
2011,
Pubmed
Houston,
Consensus docking: improving the reliability of docking in a virtual screening context.
2013,
Pubmed
Hénault,
The role of the M4 lipid-sensor in the folding, trafficking, and allosteric modulation of nicotinic acetylcholine receptors.
2015,
Pubmed
Jain,
Unorthodox Acetylcholine Binding Sites Formed by α5 and β3 Accessory Subunits in α4β2* Nicotinic Acetylcholine Receptors.
2016,
Pubmed
,
Xenbase
Jin,
A portable site: a binding element for 17β-estradiol can be placed on any subunit of a nicotinic α4β2 receptor.
2011,
Pubmed
,
Xenbase
Jin,
Synthesis and activity of substituted heteroaromatics as positive allosteric modulators for α4β2α5 nicotinic acetylcholine receptors.
2014,
Pubmed
Kelley,
A cytoplasmic region determines single-channel conductance in 5-HT3 receptors.
2003,
Pubmed
Kracun,
Influence of the M3-M4 intracellular domain upon nicotinic acetylcholine receptor assembly, targeting and function.
2008,
Pubmed
Kuryatov,
Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors.
2005,
Pubmed
Liu,
An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol.
2008,
Pubmed
Mazzaferro,
Additional acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity.
2011,
Pubmed
,
Xenbase
Mazzaferro,
α4β2 Nicotinic Acetylcholine Receptors: RELATIONSHIPS BETWEEN SUBUNIT STOICHIOMETRY AND FUNCTION AT THE SINGLE CHANNEL LEVEL.
2017,
Pubmed
McFedries,
Methods for the elucidation of protein-small molecule interactions.
2013,
Pubmed
McGaughey,
pi-Stacking interactions. Alive and well in proteins.
1998,
Pubmed
Millar,
Assembly and subunit diversity of nicotinic acetylcholine receptors.
2003,
Pubmed
Morales-Perez,
X-ray structure of the human α4β2 nicotinic receptor.
2016,
Pubmed
Morris,
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.
2009,
Pubmed
Newcombe,
Diversity of Nicotinic Acetylcholine Receptor Positive Allosteric Modulators Revealed by Mutagenesis and a Revised Structural Model.
2018,
Pubmed
,
Xenbase
Pandya,
Allosteric modulator Desformylflustrabromine relieves the inhibition of α2β2 and α4β2 nicotinic acetylcholine receptors by β-amyloid(1-42) peptide.
2011,
Pubmed
,
Xenbase
Paradiso,
Nicotine is highly effective at producing desensitization of rat alpha4beta2 neuronal nicotinic receptors.
2003,
Pubmed
Paterson,
Neuronal nicotinic receptors in the human brain.
2000,
Pubmed
,
Xenbase
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Prickaerts,
EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
2012,
Pubmed
Quadri,
Macroscopic and Microscopic Activation of α7 Nicotinic Acetylcholine Receptors by the Structurally Unrelated Allosteric Agonist-Positive Allosteric Modulators (ago-PAMs) B-973B and GAT107.
2019,
Pubmed
,
Xenbase
Quik,
α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.
2011,
Pubmed
Ray,
Probing the Allosteric Role of the α5 Subunit of α3β4α5 Nicotinic Acetylcholine Receptors by Functionally Selective Modulators and Ligands.
2017,
Pubmed
Salas,
The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo.
2003,
Pubmed
Sievers,
Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.
2011,
Pubmed
Trott,
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
2010,
Pubmed
Tuccinardi,
Extensive consensus docking evaluation for ligand pose prediction and virtual screening studies.
2014,
Pubmed
Unwin,
Refined structure of the nicotinic acetylcholine receptor at 4A resolution.
2005,
Pubmed
Unwin,
Gating movement of acetylcholine receptor caught by plunge-freezing.
2012,
Pubmed
Walsh,
Structural principles of distinct assemblies of the human α4β2 nicotinic receptor.
2018,
Pubmed
Wang,
Potential state-selective hydrogen bond formation can modulate activation and desensitization of the α7 nicotinic acetylcholine receptor.
2012,
Pubmed
Wang,
An Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors.
2015,
Pubmed
,
Xenbase
Wang,
A Novel α2/α4 Subtype-selective Positive Allosteric Modulator of Nicotinic Acetylcholine Receptors Acting from the C-tail of an α Subunit.
2015,
Pubmed
Wang,
Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.
2018,
Pubmed
Wang,
Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits.
1996,
Pubmed
,
Xenbase
Wang,
Chronic nicotine treatment up-regulates human alpha3 beta2 but not alpha3 beta4 acetylcholine receptors stably transfected in human embryonic kidney cells.
1998,
Pubmed
,
Xenbase
Williams,
Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.
2011,
Pubmed
Williams,
Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.
2011,
Pubmed
,
Xenbase
Zwart,
Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
2008,
Pubmed
,
Xenbase
daCosta,
A lipid-dependent uncoupled conformation of the acetylcholine receptor.
2009,
Pubmed
